These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26186658)

  • 21. Comparison of Pharmacokinetics and Tissue Distribution Kinetics of Roxithromycin and Expression of CYP 3A1 between Pregnant Mice and Foetuses.
    Qin Y; Xu W; Mo L; Li X; Ge B; Xiong J; Gao L; Xu P; Xue M
    Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):146-151. PubMed ID: 27611991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of rheumatic fever prophylaxis regimens.
    Thamlikitkul V; Kobwanthanakun S; Pruksachatvuthi S; Lertluknithi R
    J Int Med Res; 1992 Feb; 20(1):20-6. PubMed ID: 1568517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population-based meta-analysis of roxithromycin pharmacokinetics: dosing implications of saturable absorption and protein binding.
    Dolton MJ; D'Argenio DZ
    J Antimicrob Chemother; 2017 Apr; 72(4):1129-1136. PubMed ID: 28039274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of a fully automated high throughput liquid chromatographic/tandem mass spectrometric method for roxithromycin quantification in human plasma. Application to a bioequivalence study.
    Kousoulos C; Tsatsou G; Dotsikas Y; Apostolou C; Loukas YL
    Biomed Chromatogr; 2008 May; 22(5):494-501. PubMed ID: 18059078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of roxithromycin in human plasma by HPLC with fluorescence and UV absorbance detection: application to a pharmacokinetic study.
    Główka FK; Karaźniewicz-Łada M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):669-73. PubMed ID: 17329175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disposition of roxithromycin in the epididymis after repeated oral administration.
    Costa P; Desclaux d'Arramon F; Gouby A; Navratil H; Geny F; Galtier M; Bressolle F
    J Antimicrob Chemother; 1992 Aug; 30(2):197-201. PubMed ID: 1399928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of age on the pharmacokinetics of naftidrofuryl after single oral administration in elderly versus young healthy volunteers.
    Hulot T; Gamand S; Dupain T; Ahtoy P; Bromet M
    Arzneimittelforschung; 1998 Sep; 48(9):900-4. PubMed ID: 9793615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The diffusion of clarithromycin and roxithromycin into nasal mucosa, tonsil and lung in humans.
    Fraschini F; Scaglione F; Pintucci G; Maccarinelli G; Dugnani S; Demartini G
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():61-5. PubMed ID: 1827103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penetration of roxithromycin into gingival tissue.
    Jehl F; Kolbe R; Scheimberg A; Rosembaum M; Monteil H
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):77S-79S. PubMed ID: 1617928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing.
    Birkett DJ; Robson RA; Grgurinovich N; Tonkin A
    Ther Drug Monit; 1990 Jan; 12(1):65-71. PubMed ID: 2305423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
    Zhao RK; Cheng G; Tang J; Song J; Peng WX
    Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Metabolism of roxithromycin in dogs].
    Zhang SQ; Zhang LF; Xing J; Zhong DF
    Yao Xue Xue Bao; 2003 May; 38(5):374-9. PubMed ID: 12958844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of a novel orodispersible tablet of sildenafil in healthy subjects.
    Damle B; Duczynski G; Jeffers BW; Crownover P; Coupe A; LaBadie RR
    Clin Ther; 2014 Feb; 36(2):236-44. PubMed ID: 24447534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects.
    Castelli MC; Wong DF; Friedman K; Riley MG
    Clin Ther; 2011 Jul; 33(7):934-45. PubMed ID: 21722960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single-dose, three-period, six-sequence crossover study comparing the bioavailability of solution, suspension, and enteric-coated tablets of magnesium valproate in healthy Mexican volunteers under fasting conditions.
    Marcelín-Jiménez G; Angeles-Moreno AP; Contreras-Zavala L; Morales-Martínez M; Rivera-Espinosa L
    Clin Ther; 2009 Sep; 31(9):2002-11. PubMed ID: 19843490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal inhibitory concentrations for canine isolates and oral absorption of roxythromycin in fed and fasted dogs.
    Lavy E; Ziv G; Shem-Tov M; Glickman A
    J Vet Pharmacol Ther; 1995 Oct; 18(5):382-4. PubMed ID: 8587159
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diffusion of roxithromycin in gingival tissue].
    Jehl F; Kolbe R; Chrétien P; Rosembaum M; Monteil H
    Pathol Biol (Paris); 1991 May; 39(5):511-4. PubMed ID: 1881685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The acceptability, efficacy and safety of a new paediatric oral suspension of roxithromycin in respiratory tract infections.
    Moniot-Ville N; Chelly M; Consten L; Rosenbaum M
    J Int Med Res; 1998; 26(3):144-51. PubMed ID: 9718469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.